ClinVar Miner

Submissions for variant NM_000444.6(PHEX):c.591A>G (p.Gln197=)

dbSNP: rs1556020818
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München RCV000505462 SCV000599678 pathogenic Familial X-linked hypophosphatemic vitamin D refractory rickets 2013-11-06 criteria provided, single submitter clinical testing
Mendelics RCV000505462 SCV001141517 likely pathogenic Familial X-linked hypophosphatemic vitamin D refractory rickets 2019-05-28 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001051990 SCV001216175 pathogenic not provided 2023-02-27 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Studies have shown that this variant results in activation of a cryptic splice site and introduces a premature termination codon (PMID: 29393334). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 438544). This variant has been observed in individual(s) with hypophosphatemic rickets (PMID: 21902834, 29393334, 30682568). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change affects codon 197 of the PHEX mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PHEX protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product.
Revvity Omics, Revvity RCV000505462 SCV002018776 pathogenic Familial X-linked hypophosphatemic vitamin D refractory rickets 2022-03-21 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000505462 SCV005726061 pathogenic Familial X-linked hypophosphatemic vitamin D refractory rickets 2024-11-21 criteria provided, single submitter clinical testing Variant summary: PHEX c.591A>G alters a non-conserved nucleotide resulting in a synonymous change. Several computational tools predict a significant impact on normal splicing: Three predict the variant creates a 5' donor site. Two predict the variant creates a 3' acceptor site. Three predict the variant abolishes a cryptic 3' acceptor site. At least one publication reports experimental evidence that this variant affects mRNA splicing in patient samples (example, Cao_2022, Liao_2018) by deleting 77 bp from the 3' end of exon 5, resulting in a predicted frameshift (example, Cao_2022, Liao_2018). mRNA expression data from patient samples indicated female carriers have approximately half PHEX mRNA levels of wild type controls, suggesting nonsense mediated decay (Liao_2018), but results in male hemizygous sample(s) were unclear. The variant was absent in 183360 control chromosomes. c.591A>G has been reported in the literature in the heterozygous or hemizygous state in multiple related individuals affected with X-Linked Hypophosphatemic Rickets (example, Cao_2022, Liao_2018). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 35842615, 29393334). ClinVar contains an entry for this variant (Variation ID: 438544). Based on the evidence outlined above, the variant was classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.